Cargando…
AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists
While peptide antagonists for the gastrin-releasing peptide receptor (BB(2)R), neuromedin B receptor (BB(1)R), and bombesin (BB) receptor subtype-3 (BRS-3) exist, there is a need to develop non-peptide small molecule inhibitors for all three BBR. The BB agonist (BA)1 binds with high affinity to the...
Autores principales: | Moody, Terry W., Tashakkori, Nicole, Mantey, Samuel A., Moreno, Paola, Ramos-Alvarez, Irene, Leopoldo, Marcello, Jensen, Robert T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519534/ https://www.ncbi.nlm.nih.gov/pubmed/28785244 http://dx.doi.org/10.3389/fendo.2017.00176 |
Ejemplares similares
-
Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy
por: Moody, Terry W., et al.
Publicado: (2021) -
Stress and eating: a dual role for bombesin-like peptides
por: Merali, Z., et al.
Publicado: (2013) -
Bombesin and bombesin antagonists: studies in Swiss 3T3 cells and human small cell lung cancer.
por: Woll, P. J., et al.
Publicado: (1988) -
Neuropeptide G Protein-Coupled Receptors as Oncotargets
por: Moody, Terry W., et al.
Publicado: (2018) -
Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers
por: Bajo, A M, et al.
Publicado: (2004)